AdaptHealth Corp. AHCO
At closeNov 6, 2026, 4:00 PM EST
After hours · Nov 6, 4:00 PM ET
- YTD
- -26.41%
- 1 year
- -23.73%
- Market cap
- 1.00B
- Revenue (ttm)
- 3.44B
- Profit margin
- -11.83%
- EPS (ttm)
- -3.23
- Shares out
- 136.53M
- Forward P/E
- -40.72
- YTD return
- -26.41%
- 1-year return
- -23.73%
- Volume
- 2.29M
- Avg volume
- 2.85M
- Open
- 7.27
- Previous close
- 7.41
- Day's range
- 7.11 – 7.49
- 52-week range
- 5.22 – 13.38
- Beta
- 1.32
- Analysts
- Strong Buy
- Price target
- 8.71 (+18.9%)
- Earnings date
- Nov 3, 2026
5D +1.57 (+27.26%)
Key statistics
- Enterprise value
- 2.97B
- PEG ratio
- 0.00
- Price / sales
- 0.29
- Price / book
- 0.80
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 10.90%
- Free cash flow
- -61.28M
- Total cash
- 80.69M
- Total debt
- 2.05B
- Return on equity
- -28.37%
- Short % of float
- 9.91%
- 50-day average
- 5.97
- 200-day average
- 9.11
Analyst view
Consensus: strong buy
- Target (low)
- 7.00
- Target (mean)
- 8.71
- Target (high)
- 10.00
- Strong buy1
- Buy6
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 3, 2026
Expected Nov 3, 2026. Consensus EPS estimate -0.055.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2026 | Sep 30, 2026 | 0.3378 | — | — | — |
| Aug 4, 2026 | Jun 30, 2026 | 0.1688 | 0.06 | -0.11 | -64.45% |
| May 5, 2026 | Apr 10, 2026 | 0.0125 | -0.06 | -0.07 | -580.00% |
| Feb 24, 2026 | Dec 31, 2025 | 0.34 | 0.27 | -0.07 | -20.59% |
| Nov 4, 2025 | Sep 30, 2025 | 0.24 | 0.22 | -0.02 | -8.33% |
| Aug 5, 2025 | Jun 30, 2025 | 0.15 | 0.01 | -0.14 | -93.33% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 5, 2026 | Leerink Partners | main | Outperform | Outperform |
| Nov 4, 2026 | UBS | main | Buy | Buy |
| Sep 17, 2026 | Baird | main | Outperform | Outperform |
| Aug 6, 2026 | UBS | main | Buy | Buy |
| Aug 6, 2026 | RBC Capital | main | Outperform | Outperform |
| Aug 5, 2026 | Truist Securities | main | Buy | Buy |
About AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- adapthealth.com
News
Leerink Partners Maintains Outperform on AdaptHealth, Raises Price Target to $8 
What AdaptHealth (AHCO) Said on Its Q3 Earnings Call 
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $9 
AdaptHealth Corp. (AHCO) Q3 2026 Earnings Call Transcript 
What AdaptHealth (AHCO) Said on Its Q3 Earnings Call 
AdaptHealth Q3 2026 Earnings Call Transcript 
AdaptHealth Raises FY2026 Sales Guidance from $2.850B-$2.890B to $2.880B-$2.900B vs $2.955B Est 
AdaptHealth Q3 Sales $745.648M Miss $746.446M Estimate 
AdaptHealth Corp. Announces Third Quarter 2026 Results - Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $9
Your note
Sign in to keep a note on AHCO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARNHART TOBY SCOTT | Chief Operating Officer | Stock Award(Grant) | Jan 29, 2026 | 220,654 |
| CASHIN RICHARD M JR | Beneficial Owner of more than 10% of a Class of Security | Purchase | Mar 19, 2026 | 0 |
| CLEMENS JASON A | Chief Financial Officer | Stock Award(Grant) | Jan 29, 2026 | 673,481 |
| CURRIE HARRISS T | Chief Financial Officer | Stock Award(Grant) | Sep 8, 2026 | 141,372 |
| FOSTER SUZANNE | Chief Executive Officer | Stock Award(Grant) | Jan 29, 2026 | 924,050 |
| LUNDBERG THEODORE B. | Director | Stock Award(Grant) | Jun 23, 2026 | 892,495 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| OEP Capital Advisors, LP | 11.95% | 16,312,698 | 119.57M | Jun 29, 2026 |
| Blackrock Inc. | 11.76% | 16,061,990 | 117.73M | Jun 29, 2026 |
| Deerfield Management Company, L.P | 8.41% | 11,477,730 | 84.13M | Jun 29, 2026 |
| Skyknight Capital, L.p. | 6.28% | 8,580,443 | 62.89M | Jun 29, 2026 |
| FMR, LLC | 5.77% | 7,882,906 | 57.78M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.71% | 6,426,008 | 47.10M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Capital Trust-Fidelity Value Fund | 4.77% | 6,518,996 | 47.78M | Sep 29, 2026 |
| iShares Trust-iShares Core S&P Small-Cap ETF | 4.65% | 6,350,791 | 46.55M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.51% | 3,424,034 | 25.10M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.94% | 2,648,296 | 19.41M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.83% | 2,493,327 | 18.28M | Jun 29, 2026 |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio | 1.35% | 1,839,660 | 13.48M | Jul 30, 2026 |